Berl R Oakley Selected Research

Liposomes (Liposome)

8/2020

Identification and Validation of an Aspergillus nidulans Secondary Metabolite Derivative as an Inhibitor of the Musashi-RNA Interaction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Berl R Oakley Research Topics

Disease

3	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2014
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2014
3	Neoplasms (Cancer) 08/2020 - 09/2015
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Cystic Fibrosis (Mucoviscidosis) 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Onychomycosis (Tinea Unguium) 05/2016
1	Tauopathies 01/2014
1	Mycoses (Diseases, Fungus) 01/2013
1	Osteoporosis 07/2009

Drug/Important Bio-Agent (IBA)

2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 05/2015 - 01/2014
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	Liposomes (Liposome)IBA 08/2020
1	TubulinIBA 09/2015
1	asperbenzaldehydeIBA 01/2014
1	asperthecinIBA 01/2014
1	Emodin (Archin)IBA 07/2009
1	PolyketidesIBA 07/2009

Therapy/Procedure

2	Therapeutics 01/2017 - 01/2014
2	Drug Therapy (Chemotherapy) 05/2016 - 01/2013
1	Lung Transplantation 01/2020